HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazunori Fujitaka Selected Research

suplatast tosilate

1/2019Suplatast tosilate reduces radiation-induced lung injury in mice through suppression of oxidative stress.
1/2017Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
1/2009Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazunori Fujitaka Research Topics

Disease

29Neoplasms (Cancer)
08/2022 - 03/2011
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022 - 06/2004
21Lung Neoplasms (Lung Cancer)
08/2022 - 03/2011
17Interstitial Lung Diseases (Interstitial Lung Disease)
07/2022 - 12/2005
8Adenocarcinoma of Lung
01/2022 - 06/2011
8Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2021 - 01/2009
7Fibrosis (Cirrhosis)
01/2021 - 01/2017
7Idiopathic Pulmonary Fibrosis
01/2021 - 04/2010
6Asthma (Bronchial Asthma)
12/2022 - 01/2009
6Lung Injury
12/2021 - 04/2009
6Neoplasm Metastasis (Metastasis)
09/2020 - 03/2011
5Disease Progression
07/2022 - 12/2018
5Bronchiectasis
02/2021 - 01/2018
4Pneumonia (Pneumonitis)
10/2022 - 07/2011
4Adenocarcinoma
01/2022 - 03/2011
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2021 - 10/2017
3Venous Thromboembolism
05/2021 - 03/2019
3Emphysema
04/2021 - 01/2016
3Inflammation (Inflammations)
01/2021 - 11/2017
3Lewis Lung Carcinoma
09/2018 - 11/2013
2Respiratory Insufficiency (Respiratory Failure)
02/2022 - 01/2017
2Radiation Pneumonitis
12/2021 - 10/2021
2Hemorrhage
05/2021 - 08/2018
2Dyspnea (Shortness of Breath)
02/2021 - 12/2005
2Sarcoidosis (Schaumann Disease)
01/2021 - 05/2012
2Carcinoma (Carcinomatosis)
01/2021 - 06/2011
2Acute Lung Injury
10/2020 - 01/2020
2Chronic Obstructive Pulmonary Disease (COPD)
01/2020 - 01/2015
2Intracranial Embolism
01/2020 - 03/2019
2Malignant Mesothelioma
01/2018 - 01/2016
2Lymphangioleiomyomatosis (Lymphangiomyomatosis)
12/2017 - 01/2002
2Fever (Fevers)
12/2005 - 05/2005
2Neutropenia
05/2005 - 06/2004
1Exophthalmos (Proptosis)
12/2022
1Immunoglobulin G4-Related Disease
12/2022
1Rheumatoid Arthritis
10/2022
1Meningoencephalitis
10/2022
1Chickenpox
10/2022

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
08/2022 - 06/2008
8LigandsIBA
07/2022 - 01/2016
8Biomarkers (Surrogate Marker)IBA
01/2021 - 07/2011
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2021 - 01/2009
7Plasminogen Activators (Plasminogen Activator)IBA
01/2019 - 04/2010
7Plasminogen Activator Inhibitor 1IBA
01/2019 - 04/2010
6Tyrosine Kinase InhibitorsIBA
08/2022 - 06/2008
5Cisplatin (Platino)FDA LinkGeneric
02/2021 - 05/2005
5Small Interfering RNA (siRNA)IBA
01/2021 - 04/2010
5CytokinesIBA
01/2021 - 01/2009
4pembrolizumabIBA
01/2022 - 03/2019
4Immune Checkpoint InhibitorsIBA
12/2021 - 09/2019
4Carboplatin (JM8)FDA LinkGeneric
11/2021 - 06/2004
4Pharmaceutical PreparationsIBA
02/2021 - 07/2011
4Proteins (Proteins, Gene)FDA Link
12/2020 - 12/2015
4AntibodiesIBA
11/2019 - 12/2005
3SteroidsIBA
12/2022 - 12/2005
3Prednisolone (Predate)FDA LinkGeneric
12/2022 - 01/2018
3HMGB1 Protein (HMG1)IBA
12/2021 - 01/2020
3Gefitinib (Iressa)FDA Link
10/2021 - 06/2011
3Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2021 - 06/2011
3AntigensIBA
04/2021 - 12/2005
3Interleukin-6 (Interleukin 6)IBA
01/2021 - 04/2009
3suplatast tosilateIBA
01/2019 - 01/2009
3Bevacizumab (Avastin)FDA Link
01/2019 - 09/2018
3SK-216IBA
01/2016 - 11/2013
3Paclitaxel (Taxol)FDA LinkGeneric
10/2011 - 06/2004
2Immunoglobulin G (IgG)IBA
12/2022 - 04/2022
2osimertinibIBA
08/2022 - 01/2022
2AnticoagulantsIBA
05/2021 - 03/2019
2edoxabanIBA
05/2021 - 03/2019
2EnzymesIBA
02/2021 - 01/2012
2NivolumabIBA
02/2021 - 01/2018
2PlatinumIBA
01/2021 - 01/2019
2Messenger RNA (mRNA)IBA
01/2021 - 01/2021
2Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
01/2019 - 12/2018
2Mucin-1 (CA 15-3 Antigen)IBA
01/2019 - 12/2017
2ChemokinesIBA
01/2019 - 01/2017
2Pemetrexed (MTA)FDA Link
12/2018 - 09/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2018 - 11/2013
2PowdersIBA
09/2018 - 12/2015
2Docetaxel (Taxotere)FDA Link
09/2018 - 01/2011
2CD13 Antigens (Alanine Aminopeptidase)IBA
01/2018 - 07/2015
2Receptor for Advanced Glycation End ProductsIBA
11/2017 - 01/2017
1Interleukin-13IBA
12/2022
1GlucocorticoidsIBA
12/2022
1InterleukinsIBA
12/2022
1dupilumabIBA
12/2022
1Methotrexate (Mexate)FDA LinkGeneric
10/2022
1iguratimodIBA
10/2022
1Valacyclovir (Valtrex)FDA LinkGeneric
10/2022
1tepotinibIBA
06/2022
1capmatinibIBA
06/2022

Therapy/Procedure

19Drug Therapy (Chemotherapy)
07/2022 - 01/2011
10Therapeutics
08/2022 - 06/2011
6Radiotherapy
12/2021 - 06/2017
5Traction
02/2021 - 01/2018
4Chemoradiotherapy
12/2021 - 10/2017
2Oral Administration
10/2022 - 06/2017
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2022 - 12/2021
2Catheters
01/2020 - 01/2018
1Operative Surgical Procedures
07/2022